Detalles de la búsqueda
1.
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.
N Engl J Med
; 386(8): 713-723, 2022 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35021004
2.
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
N Engl J Med
; 386(20): 1899-1909, 2022 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35353976
3.
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
N Engl J Med
; 387(2): 109-119, 2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35731908
4.
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
N Engl J Med
; 385(1): 23-34, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34133855
5.
Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season.
Clin Infect Dis
; 76(8): 1358-1363, 2023 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36504336
6.
Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter Study.
Clin Infect Dis
; 76(11): 1980-1988, 2023 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36694363
7.
Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022.
Clin Infect Dis
; 76(6): 1030-1037, 2023 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36327388
8.
Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015-2016 Through 2019-2020.
Clin Infect Dis
; 76(3): e1031-e1039, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35867698
9.
Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US Children.
Clin Infect Dis
; 76(3): e280-e290, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717646
10.
BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 Years-United States, July 2021 - April 2022.
Clin Infect Dis
; 76(3): e90-e100, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35924406
11.
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
Clin Infect Dis
; 77(4): 547-557, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37255285
12.
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.
N Engl J Med
; 383(4): 334-346, 2020 07 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32598831
13.
The Modified Clinical Progression Scale for Pediatric Patients: Evaluation as a Severity Metric and Outcome Measure in Severe Acute Viral Respiratory Illness.
Pediatr Crit Care Med
; 24(12): 998-1009, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37539964
14.
Extracorporeal Membrane Oxygenation Characteristics and Outcomes in Children and Adolescents With COVID-19 or Multisystem Inflammatory Syndrome Admitted to U.S. ICUs.
Pediatr Crit Care Med
; 24(5): 356-371, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36995097
15.
Vaccine Effectiveness Against Influenza Hospitalization and Emergency Department Visits in 2 A(H3N2) Dominant Influenza Seasons Among Children <18 Years Old-New Vaccine Surveillance Network 2016-2017 and 2017-2018.
J Infect Dis
; 226(1): 91-96, 2022 08 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34951451
16.
Interpretation of Relative Efficacy and Effectiveness for Influenza Vaccines.
Clin Infect Dis
; 75(1): 170-175, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34875035
17.
Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
Clin Infect Dis
; 74(8): 1329-1337, 2022 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34320171
18.
Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children.
Clin Infect Dis
; 75(2): 230-238, 2022 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35024795
19.
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
Clin Infect Dis
; 74(9): 1515-1524, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358310
20.
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
MMWR Morb Mortal Wkly Rep
; 71(2): 52-58, 2022 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35025852